P55055 (NR1H2_HUMAN) Homo sapiens (Human)

Oxysterols receptor LXR-beta UniProtKBInterProSTRINGInteractive Modelling

460 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

25 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of liganded hRXR-alpha/hLXR-beta heterodimer on DNA Heteromer
P19793; Q15596;
74-457
9CR;ZN;965;
Assess
Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease Heteromer
P28702;
216-460
668;PEG;
Assess
Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazo… Heteromer
P28702;
217-460
6Y4;
Assess
Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists Heteromer
P28702; Q15596;
217-460
67S;
Assess
Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazo… Heteromer
P28702;
217-460
6Y8;
Assess
X-Ray Crystal Structure of LXR Ligand Binding Domain with 24(S),25-epoxycholesterol Heteromer
Q15788;
217-460
CO1;
Assess
X-ray crystal structure of a Potent Liver X Receptor Modulator Heteromer
Q15596;
218-460
G58;
Assess
Crystal structure of LXR ligand binding domain in complex with full agonist 1 Heteromer
Q15788;
218-458
0KS;ACT;CA;
Assess
Crystal structure of LXR ligand binding domain in complex with partial agonist 5 Heteromer
Q15788;
218-458
0KT;ACT;CA;
Assess
Human LXR-beta in complex with an agonisthomo-2-mer217-460
D40;
Assess
Human LXR-beta in complex with a ligandhomo-2-mer217-460
BQ3;
Assess
Human LXR-beta in complex with an agonisthomo-2-mer217-460
D43;
Assess
Human LXR-beta in complex with an agonisthomo-2-mer218-460
D3R;
Assess
Crystal structure of nuclear receptor subfamily 1, group h, member 2 (lxrb) complexed with partial …homo-2-mer217-457
BU1;652;
Assess
HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEXhomo-2-mer219-459
965;IPA;
Assess
HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEXhomo-2-mer218-457
BNS;44B;
Assess
CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-8…homo-2-mer218-457
6OX;BU1;
Assess
Complex Structure of LXR with an agonisthomo-2-mer218-457
61X;
Assess
HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317homo-2-mer218-457
444;
Assess
Crystal structure of the human Liver X receptor beta ligand binding domain in complex with a synthe…monomer218-460
444;
Assess
Crystal structure of the human Liver X receptor beta ligand binding domain in complex with a synthe…monomer218-460
444;
Assess
LXRbeta ligand binding domain in complex with small molecule inhibitorsmonomer218-458
KWE;
Assess
LXRbeta ligand binding domain in comlpex with small molecule inhibitorsmonomer218-458
KUW;
Assess
LXRbeta ligand binding domain in comlpex with small molecule inhibitorsmonomer218-458
KVB;
Assess
LXRbeta ligand binding domain in comlpex with small molecule inhibitorsmonomer218-458
KVK;
Assess

8 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4nqa.2.Bmonomer0.7675-458
ZN;965;98.70
Assess
4nqa.1.Bmonomer0.7475-457
ZN;965;98.70
Assess
5uan.1.Bmonomer0.6586-457
ZN;35.14
Assess
3dzy.1.Bmonomer0.6084-457
ZN;30.36
Assess
4nqa.1.Amonomer0.5984-457
ZN;28.00
Assess
4iqr.2.Amonomer0.5785-457
ZN;29.47
Assess
5uan.1.Amonomer0.5785-458
ZN;28.00
Assess
4iqr.2.Bmonomer0.5685-457
ZN;29.47
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24nqa.1.Bmonomer0.7762-360
965;92.38
Assess
Isoform 24nqa.2.Bmonomer0.7562-361
965;92.38
Assess